National Pension Service’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.13M Buy
31,352
+3,047
+11% +$404K ﹤0.01% 441
2025
Q4
$4.01M Buy
28,305
+18,354
+184% +$2.66M ﹤0.01% 466
2025
Q3
$1.4M Buy
+9,951
New +$1.35M ﹤0.01% 480
2024
Q3
Sell
-180
Closed -$24.8K 539
2024
Q2
$24.8K Sell
180
-174,150
-100% -$23.9M ﹤0.01% 530
2024
Q1
$24M Buy
174,330
+174,150
+96,750% +$23.8M 0.03% 471
2023
Q4
$23.7K Hold
180
﹤0.01% 494
2023
Q3
$20.6K Hold
180
﹤0.01% 495
2023
Q2
$17K Sell
180
-21,611
-99% -$2.11M ﹤0.01% 488
2023
Q1
$2.16M Buy
+21,791
New +$2.27M ﹤0.01% 467
2021
Q3
Sell
-10
Closed -$1K 508
2021
Q2
$1K Buy
10
+2
+25% +$192 ﹤0.01% 503
2021
Q1
$1K Sell
8
-705
-99% -$73.9K ﹤0.01% 504
2020
Q4
$68K Buy
713
+233
+49% +$22.5K ﹤0.01% 482
2020
Q3
$47K Hold
480
﹤0.01% 470
2020
Q2
$59K Buy
+480
New +$53K ﹤0.01% 466

Other funds holding NBIX

National Pension Service's NBIX Position: Q1 2026 in Review

National Pension Service increased its Neurocrine Biosciences (NBIX) stake by 11% in Q1 2026, buying an estimated $404K and bringing the position to 31,352 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #441.

National Pension Service first reported a position in NBIX in Q2 2020 and has held it in 14 quarters since. The position peaked at $24M in Q1 2024. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • National Pension Service held 31,352 shares of Neurocrine Biosciences worth $4.13M as of Q1 2026.
  • National Pension Service bought 3,047 Neurocrine Biosciences shares in Q1 2026, an estimated $404K.
  • Neurocrine Biosciences made up ﹤0.01% of National Pension Service's portfolio in Q1 2026, its #441 holding.
  • National Pension Service first reported a position in Neurocrine Biosciences in Q2 2020 and has held it in 14 quarters since.
  • National Pension Service's Neurocrine Biosciences position peaked at $24M in Q1 2024.
  • 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on National Pension Service's 13F filing for Q1 2026, filed 12 May 2026.